This inventor holds 1 USPTO granted patent. Top assignees: Monash University, Seaport Therapeutics, Inc.. Active years: 2026.
Company Filing History:
1 out of 18 
1 out of 2 Years Active: 2026
Title: Nathania Leong: Innovator in Lipid Prodrugs
Introduction
Nathania Leong is a prominent inventor based in Clayton, Australia. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of lipid prodrugs. Her innovative work focuses on improving the bioavailability of therapeutic agents, which is crucial for effective treatment.
Latest Patents
Nathania Leong holds a patent for "Lipid prodrugs of JAK inhibitors and uses thereof." This invention provides lymphatic system-directing lipid prodrugs and pharmaceutical compositions. It also includes methods for producing these prodrugs and compositions, as well as methods for treating various diseases, disorders, or conditions by administering the lipid prodrugs to patients in need.
Career Highlights
Throughout her career, Nathania has worked with notable organizations, including Seaport Therapeutics, Inc. and Monash University. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Nathania has collaborated with esteemed colleagues such as Joseph Bolen and Daniel Kenneth Bonner. These partnerships have further enhanced her research and development efforts in the pharmaceutical industry.
Conclusion
Nathania Leong is a trailblazer in the field of lipid prodrugs, with a focus on enhancing therapeutic efficacy. Her innovative patent and collaborations reflect her commitment to advancing medical science and improving patient outcomes.